Magnetic resonance (MR) has been widely used in predicting the aggressiveness of endometrioid adenocarcinoma. However, the diagnostic value of the MR volume of the lesion has been controversial.
Purpose
To determine whether the whole-lesion MR volume measurement could be used as a better predictor for evaluating the aggressiveness of endometrioid adenocarcinoma.
Material and Methods
In this retrospective study, we include 357 patients with pathologically demonstrated endometrioid adenocarcinoma at our institution between 1 January 2013 and 31 December 2018. Whole-lesion MR volume was calculated on sagittal T2-weighted images with ITK-SNAP software on a personal computer.
Results
According to the receiver operating characteristics curve analysis, whole-lesion MR volume has the competitive advantage in evaluating deep myometrial invasion compared with the frozen results, generating area under the curve (AUC) values of 0.751 vs. 0.834 (P = 0.0629, Z = 1.860). The AUC of tumor maximum diameter, simple tumor volume, and whole-lesion MR volume in predicting deep myometrial invasion was 63.8%, 67.6%, and 75.1%, respectively.
Conclusion
Whole-lesion MR volume is a good diagnostic tool for prediction of deep myometrial invasion, lymph node metastasis, and lymphovascular invasion. MR volumetry could reflect the aggressiveness of endometrioid adenocarcinoma more accurately than traditional lesion measurements.
AmantFMirzaMRKoskasM, et al.
Cancer of the corpus uteri.Int J Gynaecol Obstet2018;
143:37–50.
2.
ColomboNPretiELandoniF, et al.
Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol2013;
24:33–38.
3.
KongAJohnsonNKitchenerHC, et al.
Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.J Natl Cancer Inst2012;
104:1625–1634.
4.
SorbeBNordstromBMaenpaaJ, et al.
Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study.Int J Gynecol Cancer2009;
19:873–878.
5.
ASTEC study group, KitchenerHSwartAM, et al.
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.Lancet2009;
373:125–136.
6.
ColomboNCreutzbergCAmantF, et al.
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up.Ann Oncol2016;
27:16–41.
7.
SalaERockallAGFreemanSJ, et al.
The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know.Radiology2013;
266:717–740.
8.
TanakaTTeraiYFujiwaraS, et al.
Preoperative diffusion-weighted magnetic resonance imaging and intraoperative frozen sections for predicting the tumor grade in endometrioid endometrial cancer.Oncotarget2018;
9:36575–36584.
9.
LinGHuangYTChaoA, et al.
Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T.Eur Radiol2017;
27:1867–1876.
10.
NakamuraKNakayamaKIshikawaN, et al.
Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma.Oncotarget2018;
9:23164–23172.
11.
TodoYChoiHJKangS, et al.
Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study.Gynecol Oncol2013;
131:294–298.
12.
NougaretSReinholdCAlsharifSS, et al.
Endometrial Cancer: combined MR volumetry and diffusion-weighted imaging for assessment of myometrial and lymphovascular invasion and tumor grade.Radiology2015;
276:797–808.
13.
TakahashiSMurakamiTNarumiY, et al.
Preoperative staging of endometrial carcinoma: diagnostic effect of T2-weighted fast spin-echo MR imaging.Radiology1998;
206:539–547.
14.
NougaretSHortaMSalaE, et al.
Endometrial cancer MRI staging: updated guidelines of the European Society of Urogenital Radiology.Eur Radiol2019;
29:792–805.
15.
JiangYYouKQiuX, et al.
Tumor volume predicts local recurrence in early rectal cancer treated with radical resection: a retrospective observational study of 270 patients.Int J Surg2018;
49:68–73.
16.
LeeJHLeeSWKimJR, et al.
Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.Gynecol Oncol2017;
147:577–584.
17.
FotopoulouCEl-BalatAdu BoisA, et al.
Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer.Arch Gynecol Obstet2015;
292:1321–1327.
18.
TanakaTTeraiYOnoYJ, et al.
Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.Int J Gynecol Cancer2015;
25:879–883.
19.
TodoYWatariHOkamotoK, et al.
Tumor volume successively reflects the state of disease progression in endometrial cancer.Gynecol Oncol2013;
129:472–477.
20.
CanlorbeGBendifallahSLaasE, et al.
Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study.Ann Surg Oncol2016;
23:171–177.
21.
WeinbergLEKunosCAZanottiKM.Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.Int J Gynecol Cancer2013;
23:1438–1445.
22.
LinGHuangYTChaoA, et al.
Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T.Eur Radiol2017;
27:1867–1876.
23.
ChattopadhyaySCrossPNayarA, et al.
Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.Int J Gynecol Cancer2013;
23:690–697.
24.
Ytre-HaugeSHusbyJAMagnussenIJ, et al.
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.Int J Gynecol Cancer2015;
25:459–466.
25.
ShimSHKimDYKimHJ, et al.
Stratification of risk groups according to survival after recurrence in endometrial cancer patients.Medicine (Baltimore)2017;
96:e6920.
26.
EgginkFAMomCHBouwmanK, et al.
Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.Eur J Cancer2017;
78:82–90.
27.
TuomiTPasanenALeminenA, et al.
Prediction of lymphatic dissemination in endometrioid endometrial cancer: comparison of three risk-stratification models in a single-institution cohort.Gynecol Oncol2017;
144:510–514.
28.
StellooENoutRAOsseEM, et al.
Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC Cohorts.Clin Cancer Res2016;
22:4215–4224.
29.
YushkevichPAPashchinskiyAOguzI, et al.
User-Guided segmentation of multi-modality medical imaging datasets with ITK-SNAP.Neuroinformatics2019;
17:83–102.
